肺功能和心脏代谢疾病的发病在阻塞性肺病研究的纵向负担
Christer Janson1, James Potts2, Andrei Malinovschi3
1Department of Medical Sciences Respiratory Medicine, Uppsala Universitet, Uppsala, Sweden christer.janson@medsci.uu.se.
BMJ open respiratory research
|January 20, 2025
概括
更高的强迫生命能力 (FVC) 与降低患糖尿病,心脏病和中风等心脏代谢疾病的风险有关. 这项研究强调了FVC作为预测这些条件的关键指标.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 流行病学 流行病学
背景情况:
- 以前的研究,主要来自高收入国家,表明高强迫生命能力 (FVC) 与心脏代谢疾病风险降低之间的相关性.
- 这项研究将这一调查扩展到全球,检查各种经济环境.
研究的目的:
- 纵向评估螺旋计测量与心脏代谢疾病发病率之间的关联.
- 评估这些协会在低收入,中等收入和高收入国家.
主要方法:
- 利用了来自15个国家的5 916名参与者在阻塞性肺病负担研究中的数据.
- 在1秒内测量的支气管扩张后强迫呼气体积 (FEV1),FVC和FEV1/FVC在基线.
- 采用回归模型和随机效应元分析,调整关键的人口和生活方式因素,分析新发高血压,糖尿病,心脏病和中风的发病率.
主要成果:
- 预测FVC的百分比增加显着与患上新发糖尿病,心脏病和中风的可能性较低有关.
- 更高的FEV1也与心脏病和中风发病风险降低相关.
- 更高的FEV1/FVC比率出乎意料地与糖尿病风险增加有关.
结论:
- 低FEV1/FVC比率被认为是患心脏代谢疾病的更重要的风险因素,而不是低FEV1/FVC比率.
- 将FVC纳入心脏代谢疾病风险预测模型的潜在实用性需要进一步研究.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188
COPD: Pathogenesis and Clinical Features
244
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
244
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K


